Browse

Evaluation of the anti-inflammatory and atopic dermatitis-mitigating effects of BSASM, a multicompound preparation

Cited 5 time in Web of Science Cited 5 time in Scopus
Authors
Lee, J.; Jung, E.; Park, B.; Jung, K.; Park, J.; Kim, K.; Kim, K. H.; Park, D.
Issue Date
2004-12-14
Publisher
Elsevier
Citation
J Ethnopharmacol. 2005 Jan 4;96(1-2):211-9.
Keywords
Adjuvants, Immunologic/pharmacology/*therapeutic use/toxicityAdolescentAnti-Inflammatory Agents/pharmacology/*therapeutic use/toxicityCell LineChildCytokines/biosynthesisDermatitis, Atopic/*drug therapyDrugs, Chinese Herbal/pharmacology/therapeutic use/toxicityFemaleHumansInterleukin-2/biosynthesisInterleukin-8/biosynthesisLipopolysaccharides/pharmacologyMaleNF-kappa B/metabolism*PhytotherapyPlant Extracts/pharmacology/*therapeutic use/toxicityTime FactorsTumor Necrosis Factor-alpha/biosynthesis
Abstract
For effective management of atopic dermatitis (AD), it is important to introduce a therapeutic agent, which although having the fewest side effects, has the greatest anti-inflammatory effect. In the course of screening anti-inflammatory agents, we obtained BSASM, a mixture of several plant extracts. This study was designed to investigate the AD-mitigating effect of BSASM in patients, as well as its anti-inflammatory and immunomodulatory effects in an in vitro experiment. The anti-inflammatory effects of BSASM were evaluated by the level of production of proinflammatory cytokines. Clinical evaluation was also done using eczema area severity index (EASI) score in AD patients. BSASM inhibited LPS-induced activation of NF-kappaB promoter. In addition, LPS-induced an increase of IL-8, and the TNF-alpha production in THP-1 cells was also inhibited. These results suggest that BSASM has an anti-inflammatory activity. A clinical study in patients with AD showed that BSASM induced a reduction of EASI score, degree of pruritus, and TEWL on both the antecubital fossa and abdomen. Besides, BSASM had no irritative or allergic effects. Based on these results, we conclude that BSASM has anti-inflammatory and AD-mitigating effects.
ISSN
0378-8741 (Print)
Language
English
URI
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15588673

http://hdl.handle.net/10371/22620
DOI
https://doi.org/10.1016/j.jep.2004.09.012
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Immunology (면역학전공)Journal Papers (저널논문_면역학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse